ScholarIQanswers from OpenAlex

Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results

PaperCitations, authors & open-access status

Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results have?

ScholarIQcitation count

Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results has 40 citations in the OpenAlex counts ScholarIQ stores.

When was Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results published?

ScholarIQyear

Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results has 2012 year in the ScholarIQ index.

What is the open-access status of Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results?

ScholarIQoa status

Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results has closed oa status in the ScholarIQ index.

What is the DOI of Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results?

ScholarIQdoi

The DOI for Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results is on the source record.

What is the PMID of Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results?

ScholarIQpmid

The PMID for Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results is on the source record.

What is the OpenAlex record for Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results?

ScholarIQopenalex

The OpenAlex for Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial